Dr. Christopher Charles Nessel, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 3699 Hancock Ln, Doylestown, PA 18902 Phone: 908-240-1292 |
Dr. Martha I Lobo Marin, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 3536 Windridge Dr, Doylestown, PA 18902 Phone: 267-406-3052 |
Maryann C Galietta, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 35 Liberty Place, Doylestown, PA 18901 Phone: 267-880-6686 Fax: 267-880-6687 |
News Archive
On Dec. 21, the U.S. Food and Drug Administration approved Juxtapid (lomitapide) to reduce low-density lipoprotein (LDL) cholesterol, total cholesterol, apolipoprotein B, and non-high-density lipoprotein (non-HDL) cholesterol in patients with homozygous familial hypercholesterolemia (HoFH). Juxtapid is intended for use in combination with a low fat diet and other lipid-lowering treatments.
A recent study seeks to investigate the characteristics of individuals with breakthrough infections post-vaccination in North Carolina, USA.
Cumberland Consulting Group, a national healthcare technology implementation and project management firm, today announced that it has acquired the assets of Seattle-based Cipe Consulting Group, LLC, a growing healthcare technology consulting firm specializing in electronic health records and revenue cycle system implementation and support, including workflow and business analytics.
The impact of the COVID-19 pandemic on social contact, loneliness, wellbeing and physical activity in older adults will be the focus of a new University of Stirling study.
For medics on the battlefield and doctors in remote or developing parts of the world, getting rapid access to the drugs needed to treat patients can be challenging.
› Verified 5 days ago